| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
14,640,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0005 - $0.0005 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Internet |
| Level
III Sector: |
Search Engines & Information |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Protagenic Therapeutic is a development stage biopharmaceutical company focusing on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Co.'s proprietary compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Additionally, Co. is engaged in the research and development of follow-on compounds in the TCAP family. Co. is performing clinical trials to obtain Food and Drug Administration approval and commercialization of its product.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
8,000 |
8,000 |
| Total Buy Value |
$0 |
$0 |
$6,480 |
$6,480 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Arrow Alexander K. |
Chief Financial Officer |
• – – |
2023-10-12 |
4 |
B |
$0.81 |
$6,480 |
D/D |
8,000 |
45,815 |
2.74 |
- |
|
| Arrow Alexander K. |
Chief Financial Officer |
• – – |
2022-05-18 |
4 |
B |
$0.72 |
$5,760 |
D/D |
8,000 |
151,260 |
2.74 |
- |
|
| Arrow Alexander K. |
Chief Financial Officer |
• – – |
2022-05-17 |
4 |
B |
$0.71 |
$16,330 |
D/D |
23,000 |
143,260 |
2.74 |
- |
|
| Barrage Khalil |
Director |
– • – |
2021-05-03 |
4 |
OE |
$1.25 |
$532,500 |
D/D |
360,000 |
410,000 |
|
- |
|
| Arrow Alexander K. |
Chief Financial Officer |
• – – |
2021-04-30 |
4 |
B |
$2.29 |
$2,290 |
D/D |
1,000 |
120,260 |
2.66 |
- |
|
| Arrow Alexander K. |
Chief Financial Officer |
• – – |
2021-04-29 |
4 |
B |
$2.29 |
$2,290 |
D/D |
1,000 |
119,260 |
2.66 |
- |
|
| Armen Garo H |
See Remarks |
• • • |
2016-06-17 |
4 |
B |
$1.25 |
$75,264 |
D/D |
60,211 |
4,299,379 |
3.23 |
- |
|
| Silverman Joshua |
Director |
• • – |
2016-06-17 |
4 |
A |
$1.25 |
$56,250 |
D/D |
45,000 |
45,000 |
|
- |
|
| Armen Garo H |
See RemarksOfficer |
• • • |
2016-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
250,000 |
|
- |
|
| Armen Garo H |
See RemarksOfficer |
• • • |
2016-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,235,801 |
|
- |
|
| Barrage Khalil |
Director |
– • – |
2016-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| Arrow Alexander K. |
Chief Financial OfficerOfficer |
• – – |
2016-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,000 |
|
- |
|
| Ekizian Gregory |
Director |
– • – |
2016-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
225,000 |
|
- |
|
| Musci Raymond |
Exec VP, Corporate Development |
• • – |
2010-12-13 |
4/A |
B |
$1.97 |
$10,585 |
D/D |
5,201 |
123,955 |
2.81 |
- |
|
| Musci Raymond |
Exec VP, Corporate Development |
• • – |
2010-12-13 |
4 |
B |
$1.97 |
$10,585 |
D/D |
5,201 |
450,821 |
2.81 |
- |
|
| Musci Raymond |
Exec VP, Corporate Development |
• • – |
2010-12-10 |
4/A |
B |
$1.59 |
$17,873 |
D/D |
9,799 |
118,754 |
2.81 |
- |
|
| Musci Raymond |
Exec VP, Corporate Development |
• • – |
2010-12-10 |
4 |
B |
$1.59 |
$17,873 |
D/D |
9,799 |
445,620 |
2.81 |
- |
|
| Brilliant Digital Entertainment Inc |
10% Owner |
– – • |
2010-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,161,430 |
|
- |
|
| Dyne Mark |
Director |
– • • |
2010-06-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(20,000) |
746,369 |
|
- |
|
| Plotts Thomas |
Interim CFO |
• – – |
2010-03-31 |
4 |
D |
$0.82 |
$7,969 |
D/D |
(9,718) |
28,619 |
|
- |
|
| Plotts Thomas |
Interim CFO |
• – – |
2010-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
38,337 |
|
- |
|
| Chazen Jerome A |
Director |
– • – |
2010-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
41,049 |
53,234 |
|
- |
|
| Ellin Robert S |
Director |
– • • |
2010-01-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,323,467) |
1,792,695 |
|
- |
|
| Ellin Robert S |
Director |
– • • |
2009-12-21 |
4 |
B |
$0.60 |
$3,226 |
D/D |
5,376 |
3,116,262 |
3.84 |
- |
|
| Plotts Thomas |
Interim CFOOfficer |
• – – |
2009-12-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,337 |
|
- |
|
67 Records found
|
|
Page 1 of 3 |
|
|
